Company intelligence / Profile preview

Rensair

London, England, United Kingdomrensair.com ↗

Ownership: Private
Development stage: Commercial

Overview

Rensair’s portable air purification devices combine HEPA filtration and UVC light to achieve rapid and highly effective removal of airborne pathogens, including viruses such as coronavirus. Independent laboratory tests—including NHS biovalidation—demonstrate 99.9%+ reduction in airborne pathogens within minutes of operation. The devices are widely used in hospitals, dental practices, offices, schools, hospitality venues and transportation settings[2][6].

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device (HEPA filtration + UVC light air purification)
Industry: Therapeutic Medical Devices

Partnerships

NHS UKRonald McDonald House Charities ChicagoCity of Miami

Beyond the preview

Go deeper on Rensair.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rensair.

Explore the full profile